Age, sex, and cohort effects in a longitudinal study of trachomatous scarring

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 2, 2009, Pages 592-596

  Wolle, Meraf A ^a   Muñoz, Beatriz ^a   Mkocha, Harran ^b   West, Sheila K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Kongwa Trachoma Project   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE; ANAMNESIS; ARTICLE; BLINDNESS; CONTROLLED STUDY; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCAR FORMATION; SEX; TANZANIA; TRACHOMA; UPPER EYELID; CHILD; EPIDEMIOLOGY; INCIDENCE; INFANT; PRESCHOOL CHILD; PREVALENCE; RURAL POPULATION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CHILD, PRESCHOOL; COHORT EFFECT; FEMALE; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; PREVALENCE; RURAL POPULATION; SEX FACTORS; TANZANIA; TRACHOMA;

EID: 59449097039     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2414     Document Type: Article

References (24)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11):844-851.
2. West SK. Trachoma: new assault on an ancient disease. Prog Retin Eye Res. 2004;23(4):381-401.
3. West SK, Muñoz B, Mkocha H, Hsieh Y, Lynch M. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol. 2001;8(2-3):137-144.
4. Natividad A, Cooke G, Holland MJ, et al. A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet. 2006;7: 40-45.
5. Natividad A, Wilson J, Koch O, et al. Risk of trachomatous scarring and trichiasis in Gambia varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun. 2005;6(4): 332-340.
6. Mozzato-Chamay N, Mahdi OSM, Jallow O, Mabey DCW, Bailey RL, Conway DJ. Polymorphisms in candidate genes and risk of scarring trachoma in a Chlamydia trachomatis: endemic population. J Infect Dis. 2000;182(5):1545-1548.
7. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol. 1996;156(11):4338-4344.
8. Bobo L, Novak N, Mkocha H, Vitale S, West S, Quinn T. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect Immun. 1996;64(8): 3273-3279.
9. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331(19):1286-1292.
10. Peeling RW, Bailey RL, Conway DJ, et al. Antibody response to the 60-kDa chlamydial heat shock protein is associated with scarring trachoma. J Infect Dis. 1998;177(1):256-259.
11. Smith A, Munoz B, Hsieh Y, Bobo L, Mkocha H, West SK. OmpA genotypic evidence for persistent ocular Chlamydia trachomatis infection in Tanzanian village women. Ophthalmic Epidemiol. 2001;8(2-3):127-135.
12. West ES, Muñoz B, Mkocha H, et al. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachomahyperendemic community. Invest Ophthalmol Vis Sci. 2005;46(1): 83-87.
13. Thylefors B, Dawson CR, Jones BR, et al. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477-483.
14. Dawson CR, Jones BR, Tarrizo M. Guide to the control of trachoma. Geneva: World Health Organization; 1981:1-56.
15. West SK, Munoz B, Mkocha H, Gaydos C, Quinn T. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma-hyperendemic village. Invest Ophthalmol Vis Sci. 2007;48(4):1492-1497.
16. House J, Gaynor B, Taylor H, Lietman TM. The real challenge: can we discover why trachoma is disappearing before it is gone? Int Ophthalmol Clin. 2007;47(3):63-76.
17. Kari L, Whitmire WM, Carlson JH, et al. Pathogenic diversity among Chlamydia trachomatis ocular strains in non-human primates is affected by subtle genomic variations. J Infect Dis. 2008; 197(3):449-456.
18. Atik B, Thanh TT, Luong VQ, Lagree S, Dean D. Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection. JAMA. 2006;296(12):1488-1497.
19. Smith AG, Broman AT, Alemayehu W, et al. relationship between trachoma and chronic and acute malnutrition in children in rural Ethiopia. J Trop Pediatr. 2007;53(5):308-312.
20. Hsieh YH, Bobo LD, Quinn TC, West SK. Risk factors for trachoma: six year follow up of children ages 1-2 years. Am J Epidemiology. 2000;152(3):204-211.
21. West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in Central Tanzania. Int J Epidemiol. 1991;20(4):1088-1092.
22. Broman AT, Shum K, Munoz B, Duncan DD, West SK. Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Invest Ophthalmol Vis Sci. 2006;47(1):99-104.
23. Schwab L, Whitfield R, Ross-Degnan D, Steinkuller P, Swartwood J. The epidemiology of trachoma in rural Kenya: variation in prevalence with lifestyle and environment. Study survey Group. Ophthalmology. 1995;102(3):475-482.
24. Courtright P, Sheppard J, Schachter J, Said ME, Dawson C. Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population. Br J Ophthalmol. 1989;73(7):536-540.